Merck Ridgebacks Molnupiravir

WHO is reviewing Merck’s oral pill 

eAwaz Medicine

Washington – The WHO is currently reviewing Merck’s COVID-19 antiviral oral pill molnupiravir and it is thought that a recommendation will likely be made by early February. According to Janet Diaz, WHO lead on clinical management, WHO’S Guidelines Development Group is also getting ready to review Pfizer’s oral pill.